Literature DB >> 3600289

Direct effects of biguanides on glucose utilization in vitro.

F Purrello, D Gullo, A Brunetti, M Buscema, S Italia, I D Goldfine, R Vigneri.   

Abstract

The effect of the biguanides metformin and phenformin on glucose utilization in isolated cells was studied with IM-9 human lymphocytes. Both agents stimulated glucose consumption from the incubation media. Detectable effects of metformin were seen at 33 mumol/L and detectable effects of phenformin were seen at 1.7 mumol/L. Both agents, at similar concentrations, also stimulated [3H] 2-deoxy-D-glucose uptake. Studies with phenformin indicated that biguanides increase the Vmax of uptake without changing the Km. In contrast to the biguanides, IM-9 cells insulin did not influence either glucose consumption or [3H] 2-deoxy-D-glucose uptake. These data provide evidence, therefore, that biguanides may directly influence the cellular utilization of glucose.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3600289     DOI: 10.1016/0026-0495(87)90115-6

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  4 in total

1.  Effects of insulin, biguanide antihyperglycaemic agents and beta-adrenergic agonists on pathways of myocardial proteolysis.

Authors:  D P Thorne; T D Lockwood
Journal:  Biochem J       Date:  1990-03-15       Impact factor: 3.857

2.  Metformin enhances certain insulin actions in cultured rat hepatoma cells.

Authors:  F Purrello; D Gullo; M Buscema; V Pezzino; R Vigneri; I D Goldfine
Journal:  Diabetologia       Date:  1988-06       Impact factor: 10.122

Review 3.  Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).

Authors:  B H Wolffenbuttel; T W van Haeften
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

Review 4.  Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents. An update.

Authors:  P Marchetti; R Navalesi
Journal:  Clin Pharmacokinet       Date:  1989-02       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.